The FDA has scheduled Hemostemix's Pre-IND meeting for January 16, 2026 to review the Company's basket clinical trial protocol for the treatment of ischemia, including: The basket protocol unifies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback